|
Cook ireland ltd (manufacturer) is submitting this report on behalf of cook medical incorporated (cmi)(importer).Exemption number: e2016031.Information pertaining to section g.1 as follows: importer site contact and address: (b)(4) cook medical incorporated (cmi) 1025 acuff road p.O box 4195 bloomington indiana 47402-4195.Importer site establishment registration number: 3005580113.The zilbs-635-8-6 device of lot number c1260120 involved in this complaint was returned for evaluation, with the original packaging.The packaging was open on receipt.With the information provided, a physical examination and document based investigation was conducted.From customer testimony, the complaint device was advanced over a cook tracer metro wire guide (part number metii-35-480) of 0.035¿ diameter.A sphincterotomy and predilation were conducted prior to this occurrence.The target location was the distal common bile duct.No resistance was encountered when advancing the wire guide or introducer through the obstructed area.The complaint device was not advanced through the wall of a previously placed stent.A portion of the stent remained inside the patient.On evaluation of the returned device, it was observed that the device was returned with a broken portion of the stent.The stent portion measured as 12mm, and was noted to be the duodenal end of the stent.There was no tactile damage on the sheath.The customer complaint is confirmed as the broken portion of the stent was returned.Possible causes for this occurrence could include incorrect placement of the stent.The stent could have been placed in the wrong location as a result of the procedural technique or insufficient /stiffness strength of the outer flexor or the inner catheter, causing elastic stretching under load as the stent starts to deploy.As a result, the customer reported that the stent retracted in the duodenal papilla.The physician then used a grasping forceps to move the stent, resulting in the stent breaking, and a portion of the stent remained inside the patient.However, as the circumstances of use cannot be replicated in a laboratory environment, a definitive root cause cannot be determined.It may be noted that a project has been initiated to improve the strength of the outer flexor.From the product instruction for use: ¿warning: these metal biliary stents are not intended to be repositioned or removed after deployment in the bile duct.In case of accidental deployment or improper placement (immediately following deployment), stent should be left in place and placement of a second stent should be attempted to achieve desired result.¿ prior to distribution, all zilbs (zilver biliary) devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records did not reveal any discrepancies which could have contributed to this complaint issue.Upon review of complaints, this failure mode has not occurred previously with this lot number.Based on the information provided to date, there is no evidence to suggest any manufacturing issues associated with lot number c1260120.According to the initial reporter, the patient did not experience any adverse effects as a result of this occurrence.The procedure was completed with another stent.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
|